Liz Wool was an invited expert speaker at this meeting in Chicago, IL, USA, Novemeber 2014.
Attendees of this first meeting included representatives from each of the current 62 CTSA institutions; Todd Wilson, DO, the National Center for Advancing Translational Sciences’ (NCATS) program director; and key stakeholders, including representatives from the pharmaceuticals industry and the Federal Drug Administration (FDA). The meeting was led by co-PIs Tom Shanley, MD, from MICHR, and Richard Barohn, MD, from Frontiers, the Kansas University Medical Center’s CTSA hub.
For more information, go to http://www.ctsa-gcp.org/1st-meeting-chicago.html.
The presentation on ICHGCP guidelines overview.The presentation gives a detailed view of What is ICHGCP, Principles of ICH & GCP
IRB & IEC, Investigator, Sponsor, Clinical trial Protocol
Investigator brochures & Essential documents.
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
The presentation on ICHGCP guidelines overview.The presentation gives a detailed view of What is ICHGCP, Principles of ICH & GCP
IRB & IEC, Investigator, Sponsor, Clinical trial Protocol
Investigator brochures & Essential documents.
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
2013 ACRP-RTP 14th Annual Fall Conference Career CornerCISCRP
This information is intended to help job seekers and individuals that are new to the clinical research enterprise who are looking for employment opportunities. This was shared with participants at the Career Corner, during the 14th Annual Fall Conference of the Research Triangle Park Chapter of the Association of Clinical Research Professionals.
Identification of Early Career Researchers: How Universities and Funding Orga...ORCID, Inc
Funding agencies, universities, and research institutes all face challenges of reliably identifying their researchers and monitoring outcomes over time. All researchers—and especially early career researchers seeking to establish their careers—need to be reliably connected to their research outputs, without the confusion common, changeable names creates. Graduate students and postdoctoral researchers supported by grants also have specific challenges: if they are not the PI, they are not included in grant information; they may not even know which grant(s) they are supported by; and as a result, the existing challenges of reliably tying publications to grant funding are even more problematic. The use of the unique, persistent ORCID identifier can help support outcomes tracking and evaluation.
In 2012, the U.S. National Institutes of Health Biomedical Research Workforce Working Group made recommendations that the NIH should take to support a sustainable biomedical research workforce in the U.S. In the course of its study, working group members were “frustrated and sometimes stymied” by the lack of quality, comprehensive data about biomedical researchers. In response, NIH has recommended the development of a simple, comprehensive tracking system for trainees, implemented a shared, voluntary researcher profile system called the Science Experts Network Curriculum Vitae (SciENcv), and encouraged the adoption of unique, persistent ORCID identifiers for researchers. Additionally, NIH has begun collecting data about individuals in graduate and undergraduate student project roles who are supported by NIH grants.
Research universities like Texas A&M are also responding by incorporating the ORCID identifier into their systems, enabling the improved identification, data collection, and career outcome tracking of students and postdoctoral researchers--and educating these early career researchers about the benefits they will receive from a unique, persistent research identifier. They are also beginning to link Electronic Theses and Dissertations (ETDs) to early career researchers' ORCID records.
ORCID is an independent, non-profit organization that provides an open registry of unique and persistent identifiers for researchers and scholars. ORCID collaborates with the community to integrate ORCID identifiers into research systems and workflows, improving data management and accuracy across systems. ORCID enables interoperability between research systems worldwide, ensuring that researchers are correctly and automatically linked to their contributions. Since its launch in October 2012, ORCID has seen rapid adoption by more than 670,000 researchers and 130+ member organizations.
From Webinar 4/23/14, https://orcid.org/content/identification-early-career-researchers-how-universities-and-funding-organizations-are-using
The Consolidated Framework for Implementation Research (CFIR) is used to guide the adaptation and plan for the implementation of public health interventions. The tool is appropriate for individuals and groups involved in planning and implementing existing interventions. To see the summary statement of this tool developed by NCCMT, click here: http://www.nccmt.ca/registry/view/eng/210.html
NCCMT is one of six NCCs for Public Health in Canada. More on the NCCs at www.nccph.ca. Production of this webinar has been made possible through a financial contribution from the Public Health Agency of Canada. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.
Building Bridges Not Walls: Can We Develop Sustainable and Sharable Cost-Effe...Office of Health Economics
In this session, we discussed the potential to create an environment in which analysts develop robust and sustainable cost-effectiveness models, which can be continually developed to support health technology management. We explored and identified opportunities, barriers, and future strategies for developing and implementing key infrastructure to support collaborative and transparent cost-effectiveness models.
Author(s) and affiliation(s): Chair: Tammy Clifford, CADTH, Canada Panelists: Deborah Marshall, University of Calgary, Canada Stirling Bryan, University of British Columbia, Canada Chris Sampson, Office of Health Economics, UK Rick Chapman, Institute for Clinical and Economic Review, USA
Conference/meeting: Health Technology Assessment International (HTAi) 2018
Location: Vancouver, Canada
Date: 04/06/2018
Strengthen Dissemination, Implementation and Improvement ScienceUCLA CTSI
DII Science at UCLA: Launching a New Initiative (October 25, 2013)
Presented by: Brian Mittman, Moira Inkelas, Stefanie Vassar, Ibrahima Sankare, Arturo Martinez, Arleen Brown
The UCLA CTSI Dissemination, Implementation and Improvement (DII) Science Initiative has three main goals.
1) Expand UCLA’s competitiveness for DII funding and publication opportunities
2) Position UCLA CTSI for future renewal
3) Enhance societal impact and benefits of UCLA research and improve health care quality, health behaviors and health outcomes in Los Angeles County and beyond
The DII vision is to ensure that:
- Results of clinical studies are put into practice in Southern California to benefit diverse populations
- Local providers take part in studies of how to implement, spread and scale findings and innovations
- Research, implementation and dissemination occur seamlessly by design
- Delivery systems can work with researchers to develop system solutions
- Researchers can find delivery systems and/or provider networks with which to partner on implementation-oriented funding proposals and studies
Microsoft: A Waking Giant in Healthcare Analytics and Big DataDale Sanders
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceSC CTSI at USC and CHLA
Date: Feb 6, 2019
Topic: How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
Speaker: Dr. Zev Wisotsky is a Senior Scientist and R&D Specialist at Science Exchange, where he assists researchers in connecting with the right R&D providers for their experiments and alerts his clients to newly available technologies. Dr. Wisotsky earned his PhD in neuroscience investigating taste detection using fruit fly and mosquito models at UC Riverside. He then completed postdoctoral research at Stanford studying the role of brain regions involved in fear memory and addiction through optogenetic silencing of different brain circuits.
Overview: Science Exchange is an open marketplace for scientific research that breaks down barriers to collaboration and innovation. The platform makes it easy for researchers to access more than 6,000 services from a network of over 2,500 qualified research providers. In this webinar, you will learn how researchers can use Science Exchange to access new technologies, get competitive quotes for specific projects, and order from any service provider under a single, pre-established contract. The presentation will also include examples of successful projects and collaborations, initiated on the Science Exchange platform, that have accelerated breakthrough
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor R...NHSNWRD
"Introduction to Evidence Synthesis": Professor Rumona Dickson's presentation provided an overview of evidence synthesis and a platform to refine questions that participants wanted to answer related to their own clinical practice. The workshop also included information detailing how teams of health care professionals might access support for addressing their clinical review questions through the CPD programme of the CLAHRC NWC.
Microsoft: A Waking Giant In Healthcare Analytics and Big DataHealth Catalyst
In 2005, Northwestern Memorial Healthcare embarked upon a strategic Enterprise Data Warehousing (EDW) initiative with the Microsoft technology platform as the foundation. Dale Sanders was CIO at Northwestern and led the development of Northwestern’s Microsoft-based EDW. At that time, Microsoft as an EDW platform was not en vogue and there were many who doubted the success of the Northwestern project. While other organizations were spending millions of dollars and years developing EDW’s and analytics on other platforms, Northwestern achieved great and rapid value at a fraction of the cost of the more typical technology platforms. Now, there are more healthcare data warehouses built around Microsoft products than any other vendor. The risky bet on Microsoft in 2005 paid off.
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
In this context, Dale will talk about:
His up and down journey with Microsoft as an Air Force and healthcare CIO, and why he is now more bullish on Microsoft like never before
A quick review of the Healthcare Analytics Adoption Model and Closed Loop Analytics in healthcare, and how Microsoft products relate to both
The rise of highly specialized, cloud-based analytic services and their value to healthcare organizations’ analytics strategies
Microsoft’s transformation from a closed-system, desktop PC company to an open-system consumer and business infrastructure company
The current transition period of enterprise data warehouses between the decline of relational databases and the rise of non-relational databases, and the new Microsoft products, notably Azure and the Analytic Platform System (APS), that bridge the transition of skills and technology while still integrating with core products like Office, Active Directory, and System Center
Microsoft’s strategy with its PowerX product line, and geospatial analysis and machine learning visualization tools
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2013 ACRP-RTP 14th Annual Fall Conference Career CornerCISCRP
This information is intended to help job seekers and individuals that are new to the clinical research enterprise who are looking for employment opportunities. This was shared with participants at the Career Corner, during the 14th Annual Fall Conference of the Research Triangle Park Chapter of the Association of Clinical Research Professionals.
Identification of Early Career Researchers: How Universities and Funding Orga...ORCID, Inc
Funding agencies, universities, and research institutes all face challenges of reliably identifying their researchers and monitoring outcomes over time. All researchers—and especially early career researchers seeking to establish their careers—need to be reliably connected to their research outputs, without the confusion common, changeable names creates. Graduate students and postdoctoral researchers supported by grants also have specific challenges: if they are not the PI, they are not included in grant information; they may not even know which grant(s) they are supported by; and as a result, the existing challenges of reliably tying publications to grant funding are even more problematic. The use of the unique, persistent ORCID identifier can help support outcomes tracking and evaluation.
In 2012, the U.S. National Institutes of Health Biomedical Research Workforce Working Group made recommendations that the NIH should take to support a sustainable biomedical research workforce in the U.S. In the course of its study, working group members were “frustrated and sometimes stymied” by the lack of quality, comprehensive data about biomedical researchers. In response, NIH has recommended the development of a simple, comprehensive tracking system for trainees, implemented a shared, voluntary researcher profile system called the Science Experts Network Curriculum Vitae (SciENcv), and encouraged the adoption of unique, persistent ORCID identifiers for researchers. Additionally, NIH has begun collecting data about individuals in graduate and undergraduate student project roles who are supported by NIH grants.
Research universities like Texas A&M are also responding by incorporating the ORCID identifier into their systems, enabling the improved identification, data collection, and career outcome tracking of students and postdoctoral researchers--and educating these early career researchers about the benefits they will receive from a unique, persistent research identifier. They are also beginning to link Electronic Theses and Dissertations (ETDs) to early career researchers' ORCID records.
ORCID is an independent, non-profit organization that provides an open registry of unique and persistent identifiers for researchers and scholars. ORCID collaborates with the community to integrate ORCID identifiers into research systems and workflows, improving data management and accuracy across systems. ORCID enables interoperability between research systems worldwide, ensuring that researchers are correctly and automatically linked to their contributions. Since its launch in October 2012, ORCID has seen rapid adoption by more than 670,000 researchers and 130+ member organizations.
From Webinar 4/23/14, https://orcid.org/content/identification-early-career-researchers-how-universities-and-funding-organizations-are-using
The Consolidated Framework for Implementation Research (CFIR) is used to guide the adaptation and plan for the implementation of public health interventions. The tool is appropriate for individuals and groups involved in planning and implementing existing interventions. To see the summary statement of this tool developed by NCCMT, click here: http://www.nccmt.ca/registry/view/eng/210.html
NCCMT is one of six NCCs for Public Health in Canada. More on the NCCs at www.nccph.ca. Production of this webinar has been made possible through a financial contribution from the Public Health Agency of Canada. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.
Building Bridges Not Walls: Can We Develop Sustainable and Sharable Cost-Effe...Office of Health Economics
In this session, we discussed the potential to create an environment in which analysts develop robust and sustainable cost-effectiveness models, which can be continually developed to support health technology management. We explored and identified opportunities, barriers, and future strategies for developing and implementing key infrastructure to support collaborative and transparent cost-effectiveness models.
Author(s) and affiliation(s): Chair: Tammy Clifford, CADTH, Canada Panelists: Deborah Marshall, University of Calgary, Canada Stirling Bryan, University of British Columbia, Canada Chris Sampson, Office of Health Economics, UK Rick Chapman, Institute for Clinical and Economic Review, USA
Conference/meeting: Health Technology Assessment International (HTAi) 2018
Location: Vancouver, Canada
Date: 04/06/2018
Strengthen Dissemination, Implementation and Improvement ScienceUCLA CTSI
DII Science at UCLA: Launching a New Initiative (October 25, 2013)
Presented by: Brian Mittman, Moira Inkelas, Stefanie Vassar, Ibrahima Sankare, Arturo Martinez, Arleen Brown
The UCLA CTSI Dissemination, Implementation and Improvement (DII) Science Initiative has three main goals.
1) Expand UCLA’s competitiveness for DII funding and publication opportunities
2) Position UCLA CTSI for future renewal
3) Enhance societal impact and benefits of UCLA research and improve health care quality, health behaviors and health outcomes in Los Angeles County and beyond
The DII vision is to ensure that:
- Results of clinical studies are put into practice in Southern California to benefit diverse populations
- Local providers take part in studies of how to implement, spread and scale findings and innovations
- Research, implementation and dissemination occur seamlessly by design
- Delivery systems can work with researchers to develop system solutions
- Researchers can find delivery systems and/or provider networks with which to partner on implementation-oriented funding proposals and studies
Microsoft: A Waking Giant in Healthcare Analytics and Big DataDale Sanders
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceSC CTSI at USC and CHLA
Date: Feb 6, 2019
Topic: How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
Speaker: Dr. Zev Wisotsky is a Senior Scientist and R&D Specialist at Science Exchange, where he assists researchers in connecting with the right R&D providers for their experiments and alerts his clients to newly available technologies. Dr. Wisotsky earned his PhD in neuroscience investigating taste detection using fruit fly and mosquito models at UC Riverside. He then completed postdoctoral research at Stanford studying the role of brain regions involved in fear memory and addiction through optogenetic silencing of different brain circuits.
Overview: Science Exchange is an open marketplace for scientific research that breaks down barriers to collaboration and innovation. The platform makes it easy for researchers to access more than 6,000 services from a network of over 2,500 qualified research providers. In this webinar, you will learn how researchers can use Science Exchange to access new technologies, get competitive quotes for specific projects, and order from any service provider under a single, pre-established contract. The presentation will also include examples of successful projects and collaborations, initiated on the Science Exchange platform, that have accelerated breakthrough
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor R...NHSNWRD
"Introduction to Evidence Synthesis": Professor Rumona Dickson's presentation provided an overview of evidence synthesis and a platform to refine questions that participants wanted to answer related to their own clinical practice. The workshop also included information detailing how teams of health care professionals might access support for addressing their clinical review questions through the CPD programme of the CLAHRC NWC.
Microsoft: A Waking Giant In Healthcare Analytics and Big DataHealth Catalyst
In 2005, Northwestern Memorial Healthcare embarked upon a strategic Enterprise Data Warehousing (EDW) initiative with the Microsoft technology platform as the foundation. Dale Sanders was CIO at Northwestern and led the development of Northwestern’s Microsoft-based EDW. At that time, Microsoft as an EDW platform was not en vogue and there were many who doubted the success of the Northwestern project. While other organizations were spending millions of dollars and years developing EDW’s and analytics on other platforms, Northwestern achieved great and rapid value at a fraction of the cost of the more typical technology platforms. Now, there are more healthcare data warehouses built around Microsoft products than any other vendor. The risky bet on Microsoft in 2005 paid off.
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
In this context, Dale will talk about:
His up and down journey with Microsoft as an Air Force and healthcare CIO, and why he is now more bullish on Microsoft like never before
A quick review of the Healthcare Analytics Adoption Model and Closed Loop Analytics in healthcare, and how Microsoft products relate to both
The rise of highly specialized, cloud-based analytic services and their value to healthcare organizations’ analytics strategies
Microsoft’s transformation from a closed-system, desktop PC company to an open-system consumer and business infrastructure company
The current transition period of enterprise data warehouses between the decline of relational databases and the rise of non-relational databases, and the new Microsoft products, notably Azure and the Analytic Platform System (APS), that bridge the transition of skills and technology while still integrating with core products like Office, Active Directory, and System Center
Microsoft’s strategy with its PowerX product line, and geospatial analysis and machine learning visualization tools
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
6. Platform Capabilities
• Current client
– National Healthcare Organization
– Customized GCP e-modules
• Adobe® Captivate
• Upload into CITI system to deploy for their
organization
– Check with platform providers for similar
capability
6
11. Joint Task Force for
Clinical Trial Competency
Cognitive
Domains
“Granular
Performance
Aspects Defined
by” the
Organization
11
Sonstein,S., et.al, Moving from Compliance to Competence:
A Harmonized Core Competency Framework for the Clinical Research Professional,
Clinical Researcher, 2014
25. References
• Sonstein, S. et. al., Moving from Compliance to
Competence: A Harmonized Core Competency
Framework for the Clinical Research Professional,
Clinical Researcher, June, 2014
• Speicher, L., et. al, The Critical Need for Academic
Health Centers to Assess the Training, Support, and
Career Development Requirements of Clinical Research
Coordinators: Recommendations from the Clinical and
Translational Science Award Research Coordinator
Taskforce, CTS Journal, 2012, Vol 5, Issue 6
25
26. References
• Martin, J., What the MHRA is looking for with
competence verification, 26 September 2013
• MHRA Good Clinical Practice Guide, TSO Press, 2012
• Wool L., Good Training Practice 101: A Primer for
Employee Training Plans, The Monitor, June 2008
• Wool, L., Let’s Focus on the Learner, Education and
Training in the 21st Century, Pardigm Shift to
Performance, The Monitor, February, 2011
26